C.-C. Wang et al.
H), 0.14 (s, 9 H), 0.12 (s, 9 H), 0.10 (s, 9 H) ppm. 13C NMR J = 11.6, 4.2 Hz, 1 H, 6aЈ-H), 4.28 (dd, J = 11.5, 7.2 Hz, 1 H, 6bЈ-
FULL PAPER
(125 MHz, CDCl3): δ = 137.0, 131.7, 129.6, 97.3, 87.7, 79.7, 78.1,
H), 4.23 (dd, J = 11.8, 2.1 Hz, 1 H, 6a-H), 3.98 (dd, J = 11.8,
5.6 Hz, 1 H, 6b-H), 3.94–3.91 (m, 1 H, 5-H), 3.87 (t, J = 4.6 Hz, 1
H, 4-H), 3.83–3.81 (m, 1 H, 5Ј-H), 3.70–3.65 (m, 3 H, 2-H, 3-H,
76.2, 74.7, 74.3, 73.5, 73.2, 71.7, 63.2, 61.7, 21.2, 1.5, 1.4, 1.2, 1.0,
0.9, 0.7, 0.2 ppm. IR (thin film): ν = 2956, 1248, 1149, 833 cm–1.
˜
HRMS (ESI): calcd. for C40H84O10SSi7Na [M + Na]+ 975.4068; 3Ј-H), 3.45 (dd, J = 8.5, 3.3 Hz, 1 H, 2Ј-H), 3.40 (dd, J = 9.4,
found 975.4072.
7.5 Hz, 1 H, 4Ј-H), 2.29 (s, 3 H, CH3), 2.02 (s, 6 H, CH3 ϫ2), 0.17
(s, 9 H, TMS), 0.14 (s, 9 H, TMS), 0.12 (s, 9 H, TMS), 0.11 (s, 9
H, TMS), 0.10 (s, 9 H, TMS) ppm. 13C NMR (100 MHz, CDCl3):
δ = 170.9 (C), 170.6 (C), 137.2 (CH), 131.7 (CH), 129.66 (CH),
98.2 (CH), 88.3 (CH), 76.8 (CH), 76.4 (CH), 75.4 (CH), 74.5 (CH),
73.1 (CH), 72.5 (CH), 71.2 (CH), 65.2 (CH2), 63.9 (CH2), 21.2
(CH3), 21.0 (CH3), 20.9 (CH3), 1.27 (CH3), 1.2 (CH3), 0.97 (CH3),
p-Tolyl
2,3-Di-O-acetyl-6-O-benzyl-4-O-(2-O-acetyl-3-O-benzyl-
4,6-O-benzylidene-α-D-glucopyranosyl)-thio-β-D-glucopyranoside
(40): HMDS (198 μL, 0.936 mmol, 4.2 equiv.) and TMSOTf (4 μL,
22.2 μmol, 0.1 equiv.) were added at room temp. under a nitrogen
flow to a suspension of compound 38 (100 mg, 0.222 mmol) in
CH2Cl2 (1.0 mL), and the mixture was stirred at room temp. for
3 h. CH2Cl2 (2 mL), benzaldehyde (75 μL, 0.735 mmol, 3.3 equiv.),
and molecular sieves (4 Å, 150 mg) were added and the mixture
was stirred for another 2 h. The mixture was cooled to 0 °C, and
TMSOTf (8 μL, 44.4 μmol, 0.2 equiv.) was added. After the system
had been stirred at same temperature for 1 h, triethylsilane (86 μL,
0.535 mmol, 2.4 equiv.) and TMSOTf (4 μL, 22.2 μmol, 0.1 equiv.)
were sequentially added. After the system had been stirred for an-
other 2 h, Ac2O (67 μL, 0.713 mmol, 3.2 equiv.) and TMSOTf
(8 μL, 22.2 μmol, 0.2 equiv.) were added and the mixture was
stirred at the same temperature for another 1 h. The whole mixture
was filtered through a pad of Celite, and the filtrate was washed
with saturated NaHCO3 (aq., 10 mL). The aqueous layer was ex-
tracted with EtOAc (3ϫ15 mL), and the combined organic layers
were washed with brine, dried with anhydrous MgSO4, filtered, and
concentrated in vacuo. The residue was purified by flash column
chromatography on silica gel to provide the desired product 40
(93 mg, 0.111 mmol, 50%). [α]2D3 = +57.1 (c = 0.1, CHCl3). 1H
NMR (400 MHz, CDCl3): δ = 7.53–7.50 (m, 2 H, Ph), 7.43–7.39
(m, 5 H, Ph), 7.38–7.29 (m, 10 H, Ph), 7.08 (d, J = 8.0 Hz, 2 H,
Ph), 5.57 (s, 1 H, PhCH), 5.36 (d, J = 4.1 Hz, 1 H, 1Ј-H), 5.31 (t,
J = 9.0 Hz, 1 H, 3-H), 4.89 (d, J = 11.8 Hz, 1 H, CH2Ph), 4.84
(dd, J = 9.6, 4.1 Hz, 1 H, 2Ј-H), 4.81 (t, J = 9.4 Hz, 1 H, 2-H),
4.70 (d, J = 11.8 Hz, 1 H, CH2Ph), 4.66 (d, J = 7.6 Hz, 1 H, 1-H),
4.12 (t, J = 9.6 Hz, 1 H, 6axЈ-H), 4.10 (t, J = 6.1 Hz, 1 H, 4-H),
3.93 (t, J = 9.6 Hz, 1 H, 3Ј-H), 3.92 (dd, J = 8.0, 4.3 Hz, 1 H, 6eqЈ-
H), 3.83–3.80 (m, 2 H, 5-H, 5Ј-H), 3.69 (t, J = 9.6 Hz, 1 H, 4Ј-H),
3.66–3.60 (m, 2 H, 6a-H, 6b-H), 2.34 (s, 3 H, CH3), 2.09 (s, 3 H,
CH3), 2.06 (s, 3 H, CH3), 2.0 (s, 3 H, CH3) ppm. 13C NMR
(100 MHz, CDCl3): δ = 170.9 (C), 170.6 (C), 169.7 (C), 138.9 (C),
138.6 (C), 138.3 (C), 137.5 (C), 134.5 (CH), 129.8 (CH), 129.1
(CH), 128.5 (CH), 128.51 (CH), 128.4 (CH), 127.78 (CH), 127.73
(CH), 127.2 (C), 126.2 (CH), 101.4 (CH), 96.3 (CH), 85.1 (CH),
81.9 (CH), 78.8 (CH), 76.1 (CH), 75.0 (CH2), 73.9 (CH2), 72.5
(CH), 71.0 (CH), 70.8 (CH), 68.8 (CH2), 63.7 (CH), 21.3 (CH3),
0.91 (CH ), 0.5 (CH ) ppm. IR (thin film): ν = 2956, 1744, 1493,
˜
3
3
1146, 1249, 835 cm–1. HRMS (ESI): calcd. for C38H72O12SSi5Na
[M + Na]+ 915.3489; found 915.3484.
Supporting Information (see footnote on the first page of this arti-
1
cle): Copies of H and 13C NMR spectra of new compounds and
the 1H, 13C and 2D NMR spectra of compound 18 and 20 are
provided.
Acknowledgments
We thank Prof. Chin-Hsing Chou (NSYSU) and Dr. Der-Lii Tzou
(I.O.C., Academia Sinica) for valuable discussions. This work was
supported by the National Science Council of Taiwan (NSC) (NSC
grant number 99-2113-M-001-010-MY2).
[1] a) A. Varki, J. B. Lowe, in: Essentials of Glycobiology (Eds.: A.
Varki, D. R. Cummings, J. D. Esko, H. H. Freeze, P. Stanley,
C. R. Bertozzi, G. W. Hart, M. E. Etzler), Cold Spring Harbor,
New York, 2008, ed. 2, pp. 75–88; For recent review articles,
see: b) G. W. Hart, R. J. Copeland, Cell 2010, 143, 672–676; c)
M. von Itztein, A. P. Moran, Microbial Glycobiol. 2009, 981–
986.
[2] For recent review articles, see: a) B. Lepenies, P. H. Seeberger,
Immunopharmacol. Immunotoxicol. 2010, 32, 196–207; b) C.-Y.
Wu, C.-H. Wong, Chem. Commun. 2011, 47, 6201–3207; c)
P. H. Seeberger, D. B. Werz, Nature 2007, 446, 1046–1051.
[3] a) P. G. M. Wuts, T. W. Greene, Greene’s Protective Groups in
Organic Synthesis, 4th ed., Wiley, Hoboken NJ, 2007; b) P. J.
Kocienski, Protecting Groups, 3rd ed., Georg Thieme, Stutt-
gart, Germany, 2005.
[4] M. Filice, J. M. Guisan, J. M. Palomo, Curr. Org. Chem. 2010,
14, 516–532.
[5] a) C.-C. Wang, J.-C. Lee, S.-Y. Luo, S. S. Kulkarni, Y.-W. Hu-
ang, C.-C. Lee, K.-L. Chang, S.-C. Hung, Nature 2007, 446,
896–899; b) C.-C. Wang, S.-S. Kulkarni, J.-C. Lee, S.-Y. Luo,
S.-C. Hung, Nat. Protoc. 2008, 3, 97–113; c) K.-L. Chang,
M. M. L. Zulueta, X.-A. Liu, Y.-Q. Zhong, S.-C. Hung, J. Org.
Chem. 2010, 75, 7424–7427; d) T.-Y. Huang, M. M. L. Zulueta,
S.-C. Hung, Org. Lett. 2011, 13, 1506–1509; e) C.-C. Wang,
M. M. L. Zulueta, S.-C. Hung, Chimia 2011, 65, 54–58; f) Y.-
P. Hu, S.-Y. Lin, C.-Y. Huang, M. M. Zulueta, J.-Y. Liu, W.
Chang, S.-C. Hung, Nat. Chem. 2011, 3, 557–563.
[6] a) A. Français, D. Urban, J.-M. Beau, Angew. Chem. 2007, 119,
8816–8819; Angew. Chem. Int. Ed. 2007, 46, 8662–8665; b) Y.
Bourdreux, A. Lemétais, D. Urban, J.-M. Beau, Chem. Com-
mun. 2011, 47, 2146–2148.
21.1 (CH ), 20.9 (CH ϫ2) ppm. IR (thin film): ν = 3028, 2867,
˜
3
3
1752, 1494, 1239, 1065, 748 cm–1. HRMS (ESI): calcd. for
C46H50O13SNa [M + Na]+ 865.2870; found 865.2867.
p-Tolyl
tri-O-trimethylsilyl-α-
6-O-Acetyl-2,3-di-O-trimethylsilyl-4-O-(6-O-acetyl-2,3,4-
-glucopyranosyl)-thio-β- -glucopyranoside
D
D
(41): HMDS (670 μL, 3.15 mmol, 4.2 equiv.) and TMSOTf (13 μL,
75.1 μmol, 0.1 equiv.) was added at room temp. under a nitrogen
flow to a suspension of compound 38 (337 mg, 0.751 mmol) in
CH2Cl2 (3.4 mL). After the system had been stirred for 40 min,
pyridine (3.1 mL), acetic anhydride (1.13 mL), and acetic acid
(173 μL, 3.0 mmol, 4.0 equiv.) were added with stirring. The mix-
ture was allowed to stir at room temp. for 48 h. The mixture was
concentrated and purified by column chromatography (Hex/EtOAc
10:1) to yield 41 (463 mg, 0.515 mmol, 69%) as a colorless syrup.
[7] T. Tsunoda, M. Suzuki, R. Noyori, Tetrahedron Lett. 1980, 21,
1357–1358.
[8] a) T. Tsunoda, M. Suzuki, R. Noyori, Tetrahedron Lett. 1979,
20, 4679–4680; b) S. Hatakeyama, H. Mori, K. Kitano, H. Ya-
mada, M. Nishizawa, Tetrahedron Lett. 1994, 35, 4367–4370;
c) C.-C. Wang, J.-C. Lee, S.-Y. Luo, H.-F. Fan, C.-L. Pai, W.-
C. Yang, L.-D. Lu, S.-C. Hung, Angew. Chem. 2002, 114, 2466–
2468; Angew. Chem. Int. Ed. 2002, 41, 2360–2362; d) W.-C.
1
[α]2D3 = +53.7 (c = 0.1 , CHCl3). H NMR (600 MHz, CDCl3): δ =
7.38 (d, J = 8.0 Hz, 2 H, Ph), 7.05 (d, J = 8.0 Hz, 2 H, Ph), 4.88
(d, J = 3.3 Hz, 1 H, 1Ј-H), 4.75 (d, J = 7.3 Hz, 1 H, 1-H), 4.35 (dd,
752
www.eurjoc.org
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2012, 744–753